Performance consistency of fed-batch cultures across multiple systems used in upstream process development by Stettler, Matthieu et al.
Engineering Conferences International
ECI Digital Archives
Cell Culture Engineering XV Proceedings
Spring 5-11-2016
Performance consistency of fed-batch cultures
across multiple systems used in upstream process
development
Matthieu Stettler
Merck Serono, matthieu.stettler@merckgroup.com
Jean Marc Bielser
Merck Serono
Yolande Rouiller
Merck Serono
Martin Jordan
Merck Serono
Herve Broly
Merck Serono
Follow this and additional works at: http://dc.engconfintl.org/cellculture_xv
Part of the Biomedical Engineering and Bioengineering Commons
This Abstract is brought to you for free and open access by the Proceedings at ECI Digital Archives. It has been accepted for inclusion in Cell Culture
Engineering XV by an authorized administrator of ECI Digital Archives. For more information, please contact franco@bepress.com.
Recommended Citation
Matthieu Stettler, Jean Marc Bielser, Yolande Rouiller, Martin Jordan, and Herve Broly, "Performance consistency of fed-batch cultures
across multiple systems used in upstream process development" in "Cell Culture Engineering XV", Robert Kiss, Genentech Sarah
Harcum, Clemson University Jeff Chalmers, Ohio State University Eds, ECI Symposium Series, (2016). http://dc.engconfintl.org/
cellculture_xv/138
PERFORMANCE CONSISTENCY OF FED-BATCH CULTURES ACROSS MULTIPLE SYSTEMS USED IN 
UPSTREAM PROCESS DEVELOPMENT 
 
Matthieu Stettler, Merck Serono SA, Switzerland 
matthieu.stettler@merckgroup.com 
Jean-Marc Bielser, Merck Serono SA, Switzerland 
Yolande Rouiller, Merck Serono SA, Switzerland 
Martin Jordan, Merck Serono SA, Switzerland 
Hervé Broly, Merck Serono SA, Switzerland 
 
 
 
Key Words: Screening and selection, clonal cell lines, high-throughput,  
 
Each stage of cell culture process development requires fit for purpose tools. The selection of a fed-batch 
cultivation system is often based on throughput and cost. However, the process knowledge derived from 
different systems and scales is not necessarily identical. Hence, a careful evaluation of systems which are 
already established or newly implemented is essential. We recently introduced a novel high throughput fed-
batch screening system (1) and the objective of this study was to provide data on how it compares with other 
systems used in early and late stage cell culture process development. We describe the performance of 12 
different recombinant CHO cell lines expressing the same antibody in fed-batch culture systems ranging from a 
few hundred microliters to lab scale. The 12 cell lines were selected based on distinct phenotypes covering a 
range which can be expected in typical industrial process development projects. The cell lines were cultivated 
using the same expansion and fed-batch protocol (proprietary fed-batch system). The following cultivation 
systems were evaluated: shaking 96-deepwell plates, 50 mL vented shake tubes, micro-scale bioreactors 
(ambr15TM system) and lab-scale bioreactors (3L). The results of this study show both the limitations and the 
potential of each cultivation system and their suitability for process development, process characterization and 
scale-up. The shaking systems offer unprecedented parallel throughput but are limited with respect to culture 
control (e. g. lack of pH and pO2 control). Despite their limitations, they are expected to be used in the future as 
important tools for early process development and for the improvement of fed-batch platform processes. On the 
other hand, the data obtained from this study show that micro- and lab-scale bioreactors represent ideal tools for 
the confirmation of process consistency. Both micro- and lab-scale systems will be extensively used in the future 
to support tech transfers and perform process characterization studies. 
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